person
Wojciech J.
- Country
- Poland
- Department
- Pratia MCM Krakow
Research Overview
assignment
94
Clinical Trials ·
- Phase 1b Multicenter Open-label Study of Acalabrutinib with Bendamustine and Rituximab or Venetoclax and Rituximab in Mantle Cell Lymphoma
- Phase 1 Evaluation of PRT2527 Monotherapy and Combination with Zanubrutinib or Venetoclax in Relapsed/Refractory Hematologic Malignancies
- Phase I Study of Iberdomide and CC-98282 in Combination with R-CHOP21 for Untreated Aggressive B-Cell Lymphoma
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
444
Sites with multiple studies
Has run more than one trial at 444 of 786 partner sites.
Specializations
Lymphoma Expertise
Specializes in various forms of B-cell lymphomas, with particular focus on diffuse large B-cell lymphoma and follicular lymphoma treatment approaches.
- Classical Hodgkin Lymphoma
- Mantle Cell Lymphoma
- Primary Mediastinal B-cell Lymphoma
Leukemia Treatment
Extensive involvement in chronic lymphocytic leukemia therapeutic interventions, including novel treatment combinations and targeted therapies.
- Treatment-Naïve CLL
- Relapsed/Refractory CLL
- Small Lymphocytic Lymphoma
Additional Oncology Focus
Investigates treatments for various other oncological conditions, including multiple myeloma and specific skin cancers.
- Advanced Solid Tumors
- Melanoma
- Triple-Negative Breast Cancer
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.